Oncolytics Biotech (ONCY) Market Capitalization (2009 - 2026)

Oncolytics Biotech (ONCY) has reported Market Capitalization for 18 consecutive years, with $118.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 57.87% year-over-year to $118.4 million in Q2 2026; TTM through Jun 2026 was $118.4 million, a 57.87% increase from a year earlier, with the FY2025 full-year figure at $94.0 million, up 29.06% from the prior year.
• Market Capitalization was $118.4 million for Q2 2026 at Oncolytics Biotech, up from $94.0 million in the prior quarter.
• Over five years, Market Capitalization peaked at $159.5 million in Q2 2023 and troughed at $44.0 million in Q1 2025.
• A 5-year average of $90.3 million and a median of $78.9 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization slumped 56.53% in 2022 and surged 186.81% in 2023, its largest moves.
• Over 5 years, Market Capitalization stood at $100.0 million in 2022, then climbed by 0.51% to $100.5 million in 2023, then declined by 27.52% to $72.8 million in 2024, then advanced by 29.06% to $94.0 million in 2025, then climbed by 25.99% to $118.4 million in 2026.
• The last three Market Capitalization figures came in at $118.4 million (Q2 2026), $94.0 million (Q4 2025), and $136.4 million (Q3 2025), per Business Quant data.